HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Topical retinoic acid (tretinoin) for melasma in black patients. A vehicle-controlled clinical trial.

AbstractBACKGROUND AND DESIGN:
Melasma is an acquired, masklike, facial hyperpigmentation. The pathogenesis and treatment of melasma in black (African-American) patients is poorly understood. We investigated the efficacy of topical 0.1% all-trans-retinoic acid (tretinoin) in the treatment of melasma in black patients. Twenty-eight of 30 black patients with melasma completed a 10-month, randomized, vehicle-controlled clinical trial in which they applied either 0.1% tretinoin or vehicle cream daily to the entire face. They were evaluated clinically (using our Melasma Area and Severity Index), colorimetrically, and histologically.
RESULTS:
After 40 weeks, there was a 32% improvement in the Melasma Area and Severity Index score in the tretinoin treatment group compared with a 10% improvement in the vehicle group. Colorimetric measurements showed lightening of melasma after 40 weeks of tretinoin treatment vs vehicle. Lightening of melasma, as determined clinically, correlated well with colorimetric measurements. Histologic examination of involved skin revealed a significant decrease in epidermal pigmentation in the tretinoin group compared with the vehicle group. Side effects were limited to a mild "retinoid dermatitis" occurring in 67% of tretinoin-treated patients. Among the patients in this study in comparison with comparably recruited white patients, melasma was reported to have begun at a later age and was more likely to be in a malar distribution.
CONCLUSIONS:
This controlled study demonstrates that topical 0.1% tretinoin lightens melasma in black patients, with only mild side effects.
AuthorsC K Kimbrough-Green, C E Griffiths, L J Finkel, T A Hamilton, S M Bulengo-Ransby, C N Ellis, J J Voorhees
JournalArchives of dermatology (Arch Dermatol) Vol. 130 Issue 6 Pg. 727-33 (Jun 1994) ISSN: 0003-987X [Print] United States
PMID8002642 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Tretinoin
Topics
  • Adult
  • Aged
  • Black People
  • Colorimetry
  • Female
  • Humans
  • Male
  • Melanosis (drug therapy, pathology)
  • Middle Aged
  • Tretinoin (adverse effects, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: